Andrew Hillman Announces the Andrew Hillman Grant for Biotech to Support the Next Generation of Biotechnology Innovators ...
Mount Semeru in East Java erupted again on Feb 14,2026 with a 2000m ash column. It has erupted 41 times in a week, 308 times in 2026 so far. PVMBG warns against activities in high-risk areas near the ...
Morning Overview on MSN
EPA kills credits for hated auto start-stop feature in your car
For years, many drivers have complained about engines that cut out at every red light and then start again a moment later. That auto start-stop feature is built into a large share of recent cars and ...
In 2025, Moderna spent $3.1 billion on R&D, a 31% decrease from the $4.5 billion budget (PDF) in 2024 and a further drop from ...
Mount Ibu in North Maluku erupted again on Feb 13,2026; it has had 248 eruptions in 2026 so far. PVMBG warns against activities within 2km radius. MAGMA Indonesia recorded 595 volcanic eruptions acros ...
According to MarketsandMarkets™, the Cleanroom Technologies Market is projected to grow from about USD 9.39 billion in 2026 ...
Amid a surge in A.I. art and new technology, young artists are turning to the techniques and styles of Old Masters instead.
The global torque sensor market is witnessing sustained momentum driven by rising demand for precision measurement, expanding industrial automation, and increasing integration of smart sensing ...
23hon MSN
PDF Solutions anticipates 20% revenue growth in 2026 as AI-driven collaboration accelerates
Q4 2025 Management View John Kibarian, Co-Founder, President, CEO & Director, highlighted that 2025 was "a transformative year for PDF." He emphasized the company's evolution from an analytics ...
Rising urban development, growing residential and commercial construction activity, and increasing consumer preference for aesthetically advanced and ...
In ALIGN study, Vanrafia (atrasentan) showed positive difference in eGFR change from baseline vs. placebo at Week 136, 4 weeks after study treatment ended1Results favored Vanrafia across multiple ...
In ALIGN study, Vanrafia (atrasentan) showed positive difference in eGFR change from baseline vs. placebo at Week 136, 4 weeks after study treatment ended1Results favored Vanrafia across multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results